MCF Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.94M | Buy |
24,309
+5,073
| +26% | +$586K | 0.13% | 87 |
|
|
2025
Q4 | $2.04M | Buy |
19,236
+3,435
| +22% | +$322K | 0.11% | 88 |
|
|
2025
Q3 | $1.34M | Sell |
15,801
-25
| -0.2% | -$2.06K | 0.08% | 85 |
|
|
2025
Q2 | $1.26M | Buy |
15,826
+513
| +3% | +$40.8K | 0.08% | 80 |
|
|
2025
Q1 | $1.38M | Sell |
15,313
-1,247
| -8% | -$116K | 0.1% | 71 |
|
|
2024
Q4 | $1.66M | Sell |
16,560
-620
| -4% | -$63.9K | 0.12% | 61 |
|
|
2024
Q3 | $1.96M | Buy |
17,180
+284
| +2% | +$33.7K | 0.14% | 54 |
|
|
2024
Q2 | $2.1M | Buy |
16,896
+293
| +2% | +$37.7K | 0.16% | 51 |
|
|
2024
Q1 | $2.2M | Buy |
16,603
+807
| +5% | +$99.5K | 0.17% | 50 |
|
|
2023
Q4 | $1.73M | Sell |
15,796
-168
| -1% | -$17.4K | 0.14% | 53 |
|
|
2023
Q3 | $1.65M | Buy |
15,964
+1,094
| +7% | +$118K | 0.15% | 55 |
|
|
2023
Q2 | $1.72M | Buy |
14,870
+222
| +2% | +$25.2K | 0.16% | 46 |
|
|
2023
Q1 | $1.57M | Buy |
14,648
+3,326
| +29% | +$359K | 0.15% | 46 |
|
|
2022
Q4 | $1.26M | Buy |
11,322
+426
| +4% | +$43.5K | 0.13% | 56 |
|
|
2022
Q3 | $942K | Buy |
10,896
+270
| +3% | +$24.1K | 0.1% | 68 |
|
|
2022
Q2 | $973K | Buy |
10,626
+338
| +3% | +$30K | 0.1% | 61 |
|
|
2022
Q1 | $844K | Buy |
+10,288
| New | +$811K | 0.08% | 72 |
|
|
2021
Q4 | – | Sell |
-9,439
| Closed | -$709K | – | 444 |
|
|
2021
Q3 | $709K | Buy |
9,439
+641
| +7% | +$48.8K | 0.07% | 75 |
|
|
2021
Q2 | $684K | Buy |
8,798
+2,044
| +30% | +$152K | 0.07% | 76 |
|
|
2021
Q1 | $497K | Sell |
6,754
-109
| -2% | -$8.04K | 0.06% | 86 |
|
|
2020
Q4 | $536K | Sell |
6,863
-2,243
| -25% | -$172K | 0.06% | 72 |
|
|
2020
Q3 | $721K | Buy |
9,106
+2,772
| +44% | +$217K | 0.1% | 59 |
|
|
2020
Q2 | $467K | Hold |
6,334
| – | – | 0.07% | 78 |
|
|
2020
Q1 | $465K | Sell |
6,334
-823
| -11% | -$64.7K | 0.08% | 73 |
|
|
2019
Q4 | $621K | Buy |
7,157
+235
| +3% | +$19.3K | 0.09% | 74 |
|
|
2019
Q3 | $556K | Buy |
6,922
+11
| +0.2% | +$882 | 0.09% | 76 |
|
|
2019
Q2 | $553K | Hold |
6,911
| – | – | 0.09% | 74 |
|
|
2019
Q1 | $548K | Sell |
6,911
-772
| -10% | -$57.7K | 0.09% | 75 |
|
|
2018
Q4 | $560K | Buy |
7,683
+88
| +1% | +$6.21K | 0.11% | 70 |
|
|
2018
Q3 | $514K | Buy |
7,595
+7
| +0.1% | +$446 | 0.09% | 73 |
|
|
2018
Q2 | $439K | Sell |
7,588
-393
| -5% | -$22.2K | 0.08% | 79 |
|
|
2018
Q1 | $415K | Buy |
7,981
+3
| +0% | +$162 | 0.08% | 76 |
|
|
2017
Q4 | $428K | Sell |
7,978
-1,630
| -17% | -$90.4K | 0.08% | 72 |
|
|
2017
Q3 | $587K | Buy |
9,608
+69
| +0.7% | +$4.18K | 0.12% | 56 |
|
|
2017
Q2 | $583K | Sell |
9,539
-168
| -2% | -$10.2K | 0.12% | 47 |
|
|
2017
Q1 | $589K | Buy |
9,707
+891
| +10% | +$54.1K | 0.12% | 48 |
|
|
2016
Q4 | $495K | Buy |
8,816
+39
| +0.4% | +$2.28K | 0.11% | 54 |
|
|
2016
Q3 | $523K | Sell |
8,777
-661
| -7% | -$38.7K | 0.12% | 54 |
|
|
2016
Q2 | $519K | Buy |
9,438
+267
| +3% | +$14.2K | 0.13% | 55 |
|
|
2016
Q1 | $463K | Sell |
9,171
-1,029
| -10% | -$50.4K | 0.12% | 51 |
|
|
2015
Q4 | $514K | Sell |
10,200
-9
| -0.1% | -$454 | 0.14% | 47 |
|
|
2015
Q3 | $481K | Buy |
10,209
+53
| +0.5% | +$2.81K | 0.12% | 47 |
|
|
2015
Q2 | $552K | Buy |
10,156
+68
| +0.7% | +$3.81K | 0.14% | 40 |
|
|
2015
Q1 | $553K | Buy |
10,088
+48
| +0.5% | +$2.72K | 0.14% | 38 |
|
|
2014
Q4 | $544K | Sell |
10,040
-420
| -4% | -$23.4K | 0.15% | 42 |
|
|
2014
Q3 | $567K | Buy |
10,460
+232
| +2% | +$13K | 0.17% | 45 |
|
|
2014
Q2 | $554K | Sell |
10,228
-1,074
| -10% | -$58.6K | 0.17% | 41 |
|
|
2014
Q1 | $612K | Buy |
11,302
+3,788
| +50% | +$196K | 0.21% | 38 |
|
|
2013
Q4 | $407K | Buy |
7,514
+512
| +7% | +$23.4K | 0.14% | 51 |
|
|
2013
Q3 | $379K | Buy |
7,002
+421
| +6% | +$19.2K | 0.21% | 50 |
|
|
2013
Q2 | $357K | Buy |
+6,581
| New | +$294K | 0.21% | 50 |
|
Other funds holding MRK
VCM
VPM
MCF Advisors's MRK Position: Q1 2026 in Review
MCF Advisors increased its Merck (MRK) stake by 26% in Q1 2026, buying an estimated $586K and bringing the position to 24,309 shares worth $2.94M. The position accounts for 0.13% of the portfolio, ranked #87.
MCF Advisors first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- MCF Advisors held 24,309 shares of Merck worth $2.94M as of Q1 2026.
- MCF Advisors bought 5,073 Merck shares in Q1 2026, an estimated $586K.
- Merck made up 0.13% of MCF Advisors's portfolio in Q1 2026, its #87 holding.
- MCF Advisors first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.